Johnson & Johnson has been ordered to pay $18.8M to a California man who claimed he developed cancer from the company’s talc-based baby powder products, Reuters’ Brendan Pierson reports. The jury ruled in favor of Emory Hernandez Valadez, who filed a lawsuit last year against the company in California state court after he said he developed mesothelioma, the author notes.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on JNJ:
- Johnson & Johnson Stock (NYSE:JNJ): Medicare Negotiations and Q2 Earnings in Focus
- J&J files suit against HHS, CMS over drug pricing provisions of IRA
- LianBio partner NANOBIOTIX enters license agreement with JanssenJohnson & Johnson
- JNJ Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Nanobiotix jumps 56% to $7.85 after global licensing pact with Janssen